Forward Pharma A/S Overview
Latest P/E ratio for Forward Pharma A/S: 2166.67 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow2166.67
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, FWP shows a P/E ratio of 2166.67. That is above the Healthcare sector average of 19.01. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 19.01. Forward Pharma A/S is at 2166.67, which is higher that average. That is roughly 11297.5% above the sector mean. Use the comparison chart on this page to see how FWP stacks up against individual peers as well.
Investors watch FWP's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Forward Pharma A/S's latest reading is 2166.67. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Forward Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 2166.67) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 19.01, while FWP is at 2166.67. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
